These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9635386)

  • 1. Comparison of insulin regimens and administration modalities in pregnancy complicated by diabetes.
    Schuster MW; Chauhan SP; McLaughlin BN; Perry KG; Morrison JC
    J Miss State Med Assoc; 1998 Jun; 39(6):208-12. PubMed ID: 9635386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin regimens and administration modalities in pregnancy complicated by diabetes.
    Schuster MW; Chauhan SP; McLaughlin BN; Perry KG; Morrison JC
    J Miss State Med Assoc; 1998 Feb; 39(2):51-5. PubMed ID: 9476446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion.
    Carr KJ; Idama TO; Masson EA; Ellis K; Lindow SW
    J Obstet Gynaecol; 2004 Jun; 24(4):382-6. PubMed ID: 15203576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study.
    Negrato CA; Rafacho A; Negrato G; Teixeira MF; Araújo CA; Vieira L; Silva CA; Date SK; Demarchi AC; Gomes MB
    Diabetes Res Clin Pract; 2010 Jul; 89(1):46-51. PubMed ID: 20378197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
    Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
    J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
    Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
    Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of insulin glargine during pregnancy: a case-control pilot study.
    Price N; Bartlett C; Gillmer M
    BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage accuracy of self-mixed vs premixed insulin.
    Bell DS; Clements RS; Perentesis G; Roddam R; Wagenknecht L
    Arch Intern Med; 1991 Nov; 151(11):2265-9. PubMed ID: 1953232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women.
    Torlone E; Gennarini A; Ricci NB; Bolli GB
    Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):238-9. PubMed ID: 16806646
    [No Abstract]   [Full Text] [Related]  

  • 18. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients.
    Lee IT; Liu HC; Liau YJ; Lee WJ; Huang CN; Sheu WH
    J Eval Clin Pract; 2009 Aug; 15(4):699-703. PubMed ID: 19674222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.